Page last updated: 2024-10-26

ebselen and Cirrhoses, Experimental Liver

ebselen has been researched along with Cirrhoses, Experimental Liver in 1 studies

ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.

Research Excerpts

ExcerptRelevanceReference
"Treatment with ebselen reduced steady-state levels of transforming growth factor-beta1, procollagen I and III, tissue inhibitor of metalloproteinase-1, cytochrome P4502E1 and placental form glutathione-S-transferase transcripts, and increased transcripts of matrix metalloproteinase-13."1.31Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats. ( Lim, GY; Ong, CN; Tan, CE; Wasser, S, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wasser, S1
Lim, GY1
Ong, CN1
Tan, CE1

Other Studies

1 other study available for ebselen and Cirrhoses, Experimental Liver

ArticleYear
Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats.
    Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:11

    Topics: Animals; Antioxidants; Azoles; Cytochrome P-450 CYP2E1; Glutathione Transferase; Isoindoles; Liver C

2001